자가면역·염증성 · TNF-α

AntibodystaleAsan Medical CenterApproved

Standard infliximab intravenous therapy (Standard infliximab intravenous therapy)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2

adalimumab (Humira, Standard-Dose Adalimumab)

Crohn Disease (CD) · Crohn Disease (CD)

AntibodystaleJanssenApproved

Standard-Dose infliximab (Standard-Dose infliximab)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2

#CD#Antibody#Approved#항체#면역항체+2

adalimumab (Humira, Start adalimumab in monotherapy)

CD · CD

AntibodystaleAsan Medical CenterApproved

TDM-based infliximab intravenous therapy (TDM-based infliximab intravenous therapy)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3

#ArthritisRheumatoid#Antibody#Approved#항체#면역항체+5

infliximab, adalimumab, etanercept (TNF blockers, TNF blockers (infliximab, adalimumab, etanercept))

Arthritis, Rheumatoid; Spondylitis, Ankylosing · Arthritis, Rheumatoid

AntibodystaleUniversity of CalgaryApproved

adalimumab (Humira, TNFa Antagonist - Adalimumab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2

AntibodystaleUniversity of CalgaryApproved

TNFa Antagonist - Infliximab (TNFa Antagonist - Infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2

AntibodystaleRabin Medical CenterPreclinical

adalimumab (Humira, Treatment with Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2

AntibodystaleJanssenApproved

Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab (Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2

#Infection#Antibody#Preclinical#항체#면역항체+3

etanercept, infliximab, adalimumab, and golimumab (Tumor Necrosis Factor Inhibitor, Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab))

Infection; Rheumatoid Arthritis · Infection

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2

up to 9 months exposure (adalimumab, adalimumab (up to 9 months exposure))

Rheumatoid Arthritis · Rheumatoid Arthritis

임상시험 1상태 DISCONTINUED

#Psoriasi#Antibody#Preclinical#항체#면역항체+2

adalimumab (Humira, adalimumab and methotrexate)

Psoriasi · Psoriasi

효능 ORR 6.35%임상시험 1상태 ACTIVE

#InflamatoryBowelDiseaseCrohn39sa#Antibody#Preclinical#항체#면역항체+4

ustekinumab (Stelara, adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab)

Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) · Inflamatory Bowel Disease (Crohn's a

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2

adalimumab (Humira, adalimumab, plus prednisone)

Rheumatoid Arthritis · Rheumatoid Arthritis

#Immunoclassification#Antibody#Preclinical#항체#면역항체+3

adalimumab (Humira, adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate)

Immunoclassification; Psoriasis · Immunoclassification

AntibodystaleAbbViePhase 1

adalimumab (Humira, adalimumab-US source)

Healthy · Healthy

#Healthy#Antibody#Phase1#항체#면역항체+2

AntibodystaleJanssenPhase 2

anti TNFa monoclonal antibody - Infliximab (anti TNFa monoclonal antibody - Infliximab)

Endometriosis · Endometriosis

#Endometriosis#Antibody#Phase2#항체#면역항체+2